Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors
- 30 April 2000
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 139 (4) , 609-617
- https://doi.org/10.1016/s0002-8703(00)90037-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) RegistryEuropean Heart Journal, 1999
- Heart failure between 1986 and 1994: Temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical centerAmerican Heart Journal, 1997
- Heart Failure Treatment With Angiotensin-Converting Enzyme Inhibitors in Hospitalized Medicare Patients in 10 Large StatesArchives of internal medicine (1960), 1997
- Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.Journal of Clinical Investigation, 1997
- Reasons for Underuse of Angiotensin-Converting Enzyme Inhibitors in Patients With Heart Failure and Left Ventricular DysfunctionThe American Journal of Cardiology, 1997
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)Published by Elsevier ,1997
- Role of Bradykinin in Mediating Vascular Effects of Angiotensin-Converting Enzyme Inhibitors in HumansCirculation, 1997
- Mortality Risk and Patterns of Practice in 4606 Acute Care Patients With Congestive Heart FailureArchives of internal medicine (1960), 1996
- Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 1995
- Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendanAmerican Heart Journal, 1992